Skip to main content

M162 M162 (Didanosine Delayed Release 400 mg)

Pill with imprint M162 M162 is White & Yellow, Capsule-shape and has been identified as Didanosine Delayed Release 400 mg. It is supplied by Mylan Pharmaceuticals Inc..

Didanosine is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M162 M162

Didanosine delayed release 400 mg M162 M162

Didanosine Delayed Release

Imprint
M162 M162
Strength
400 mg
Color
White & Yellow
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (nrtis)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8889 (Discontinued)
Inactive Ingredients
ferrosoferric oxide, carboxymethylcellulose sodium, silicon dioxide, diethyl phthalate, gelatin, hypromelloses, methacrylic acid - methyl methacrylate copolymer (1:1), propylene glycol, ferric oxide red, shellac, trisodium citrate dihydrate, sodium lauryl sulfate, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, ferric oxide yellow, potassium hydroxide, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M162 M162"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.